Intellectual Property (1,173)

Browse by Subcategory

License Agreements (1,137)
Trademark Agreements (36)

Browse by Industry

Aerospace & Defense (6)
Air Freight & Logistics (1)
Auto Components (2)
Banks (2)
Beverages (7)
Biotechnology (438)
Building Products (1)
Capital Markets (40)
Chemicals (5)
Commercial Services & Supplies (1)
Communications Equipment (1)
Construction & Engineering (2)
Distributors (1)
Diversified Consumer Services (1)
Diversified Financial Services (1)
Diversified Telecommunication Services (2)
Electrical Equipment (2)
Electronic Equipment, Instruments & Components (2)
Energy Equipment & Services (5)
Entertainment (11)
Food & Staples Retailing (1)
Food Products (5)
Health Care Equipment & Supplies (42)
Health Care Providers & Services (15)
Health Care Technology (7)
Hotels, Restaurants & Leisure (10)
Household Durables (3)
Household Products (1)
Interactive Media & Services (5)
IT Services (6)
Leisure Products (4)
Life Sciences Tools & Services (19)
Machinery (2)
Media (4)
Metals & Mining (5)
Mortgage Real Estate Investment Trusts (REITs) (1)
Oil, Gas & Consumable Fuels (7)
Personal Products (3)
Pharmaceuticals (143)
Professional Services (2)
Semiconductors & Semiconductor Equipment (5)
Software (30)
Specialty Retail (7)
Technology Hardware, Storage & Peripherals (2)
Textiles, Apparel & Luxury Goods (8)
Trading Companies & Distributors (2)
Wireless Telecommunication Services (3)
Unassigned Industry (300)

Recent Contracts

License Agreement, dated as of October 3, 2019, by and between the Regents of the University of California and the Registrant (Decibel Therapeutics, Inc., Filed With SEC on January 22, 2021)
Standard Exclusive License Agreement, dated as of October 29, 2020, by and between the University of Florida Research Foundation, Incorporated and the Registrant (Decibel Therapeutics, Inc., Filed With SEC on January 22, 2021)
Exclusive License Agreement, dated as of August 26, 2019, by and between the Curators of the University of Missouri and the Registrant (Decibel Therapeutics, Inc., Filed With SEC on January 22, 2021)
Amended and Restated License Agreement, dated as of December 9, 2016, by and between Bioventus LLC, Q-Med AB and Nestl Skin Health S.A (Bioventus Inc., Filed With SEC on January 20, 2021)
Exclusive License, Supply and Distribution Agreement, dated as of February 9, 2016, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC (Bioventus Inc., Filed With SEC on January 20, 2021)
Amendment No. 1 to Exclusive License, Supply and Distribution Agreement, dated as of December 31, 2018, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC (Bioventus Inc., Filed With SEC on January 20, 2021)
Amended and Restated Exclusive License Agreement, by and between the Johns Hopkins University and NexImmune, Inc., dated June 21, 2011 (NexImmune, Inc., Filed With SEC on January 19, 2021)
Exclusive License Agreement dated November 20, 2014 between the University of Miami and Longeveron LLC (LONGEVERON LLC, Filed With SEC on January 19, 2021)
Amendment to Exclusive License Agreement dated December 11, 2017 between the University of Miami and Longeveron LLC (LONGEVERON LLC, Filed With SEC on January 19, 2021)
License Agreement dated December 22, 2016 between JMHMD Holdings, LLC and Longeveron LLC (LONGEVERON LLC, Filed With SEC on January 19, 2021)